ROHAN PALEKAR

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ROHAN PALEKAR:

Company Role Class Num Shares Value Price $ Report Date Ownership
89bio, Inc. Chief Executive Officer, Director Common Stock 0 $0 $14.70 30 Oct 2025 Direct
Neurogene Inc. Director Non-Qualified Stock Option (right to buy) 12,050 12 Jun 2025 Direct
Neurogene Inc. Director Stock Option (Right to Buy) 7,700 14 Jun 2024 Direct
89bio, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 30 Oct 2025 Direct

Insider Reports Filed by ROHAN PALEKAR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ETNB 89bio, Inc. 30 Oct 2025 10 $0 4 Chief Executive Officer, Director 30 Oct 2025, 20:22
ETNB 89bio, Inc. 01 Aug 2025 1 -$511,458 4 Chief Executive Officer, Director 05 Aug 2025, 20:06
NGNE Neurogene Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 12:06
ETNB 89bio, Inc. 17 Feb 2025 1 -$34,342 4 Chief Executive Officer, Director 19 Feb 2025, 16:01
ETNB 89bio, Inc. 09 Feb 2025 1 -$102,074 4 Chief Executive Officer, Director 11 Feb 2025, 16:01
ETNB 89bio, Inc. 01 Feb 2025 4 -$92,141 4 Chief Executive Officer, Director 04 Feb 2025, 21:32
ETNB 89bio, Inc. 06 Dec 2024 1 +$39,450 4 Chief Executive Officer, Director 10 Dec 2024, 06:02
ETNB 89bio, Inc. 22 Nov 2024 1 +$83,500 4 Chief Executive Officer, Director 25 Nov 2024, 06:05
ETNB 89bio, Inc. 17 Aug 2024 1 -$36,992 4 Chief Executive Officer, Director 19 Aug 2024, 17:29
NGNE Neurogene Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 14:37
ETNB 89bio, Inc. 01 Apr 2024 3 -$526,903 4 Chief Executive Officer, Director 03 Apr 2024, 16:01
ETNB 89bio, Inc. 26 Feb 2024 1 -$48,173 4 Chief Executive Officer, Director 28 Feb 2024, 18:43
ETNB 89bio, Inc. 17 Feb 2024 1 -$44,823 4 Chief Executive Officer, Director 23 Feb 2024, 20:51
ETNB 89bio, Inc. 09 Feb 2024 1 -$107,062 4 Chief Executive Officer, Director 13 Feb 2024, 20:58
ETNB 89bio, Inc. 01 Feb 2024 3 -$49,666 4 Chief Executive Officer, Director 05 Feb 2024, 20:16
NGNE Neurogene Inc. 16 Jan 2024 1 $0 4 Director 18 Jan 2024, 18:58
ETNB 89bio, Inc. 05 Jan 2024 2 -$317,202 4 Chief Executive Officer, Director 08 Jan 2024, 18:31
ETNB 89bio, Inc. 29 Dec 2023 3 -$463,500 4 Chief Executive Officer, Director 03 Jan 2024, 16:54
ETNB 89bio, Inc. 17 Aug 2023 1 -$69,585 4 Chief Executive Officer, Director 21 Aug 2023, 17:49
ETNB 89bio, Inc. 30 Jun 2023 2 -$313,187 4 Chief Executive Officer, Director 05 Jul 2023, 20:39
NLTX Neoleukin Therapeutics, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:27
ETNB 89bio, Inc. 05 Jun 2023 3 -$271,050 4 Chief Executive Officer, Director 07 Jun 2023, 17:04
ETNB 89bio, Inc. 31 Mar 2023 2 -$235,197 4 Chief Executive Officer, Director 04 Apr 2023, 16:18
ETNB 89bio, Inc. 23 Mar 2023 1 -$240,000 4 Chief Executive Officer, Director 27 Mar 2023, 19:18
ETNB 89bio, Inc. 17 Feb 2023 1 -$87,718 4 Chief Executive Officer, Director 22 Feb 2023, 17:38
ETNB 89bio, Inc. 09 Feb 2023 2 $0 4 Chief Executive Officer, Director 13 Feb 2023, 16:42
ETNB 89bio, Inc. 05 Feb 2023 1 -$53,993 4 Chief Executive Officer, Director 07 Feb 2023, 18:36
ETNB 89bio, Inc. 28 Sep 2022 2 -$66,396 4 Chief Executive Officer, Director 30 Sep 2022, 19:02
ETNB 89bio, Inc. 08 Sep 2022 2 +$193,000 4 Chief Executive Officer, Director 09 Sep 2022, 16:39
NLTX Neoleukin Therapeutics, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 18:26
NLTX Neoleukin Therapeutics, Inc. 02 Mar 2022 1 $0 4 Director 04 Mar 2022, 17:12
NLTX Neoleukin Therapeutics, Inc. 02 Mar 2022 0 $0 3 Director 04 Mar 2022, 16:28
ETNB 89bio, Inc. 17 Feb 2022 2 $0 4 Chief Executive Officer, Director 22 Feb 2022, 16:06
ETNB 89bio, Inc. 05 Feb 2022 1 -$21,380 4 Chief Executive Officer, Director 13 Apr 2022, 16:05
ETNB 89bio, Inc. 27 Jan 2022 2 +$52,850 4 Chief Executive Officer, Director 31 Jan 2022, 15:30
ETNB 89bio, Inc. 07 Jul 2021 2 +$117,850 4 Chief Executive Officer, Director 08 Jul 2021, 16:05